According to Zhitong Finance App, Lai Kai Pharmaceutical-B (02105) announced that on September 8, 2026, the company will issue a total of 273,000 common shares to satisfy the ownership of RSU granted under the 2024 Share Award Program.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.